Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Nasdaq

Otter Tail's Ex-Dividend Date Is Thursday, Here's What You Need To Know

Wednesday marks the last chance for investors to receive the next dividend payout from Otter Tail (NASDAQ:OTTR).

Benzinga

Tetra Tech's Ex-Dividend Date Is Thursday, Here's What You Need To Know

Wednesday marks the last chance for investors to receive the next dividend payout from Tetra Tech (NASDAQ:TTEK).

Benzinga

Why This Match Group Analyst Is Swiping Right

Match Group Inc (NASDAQ: MTCH) reported strong first-quarter results, despite headwinds.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

SSR Mining: Dividend Insights

Wednesday marks the last chance for investors to receive the next dividend payout from SSR Mining (NASDAQ:SSRM).

Benzinga

Wednesday Is Your Last Chance To Buy Midland States Bancorp Before The Dividend Payout

Wednesday marks the last chance for investors to receive the next dividend payout from Midland States Bancorp (NASDAQ:MSBI).

Benzinga

Why Tesla Shares Are Diving Today

Shares of several companies in the auto & auto component space, including Tesla Inc (NASDAQ: TSLA), are trading lower amid market weakness as traders continue to digest Wednesday’s Fed rate hike announcement. A gain in treasury yields has weighed on technology and growth stocks.

Benzinga

Tesla Refuses To Integrate Apple's CarPlay — You Can Do It Anyway

Apple Inc.'s (NASDAQ: AAPL) CarPlay car integration standard has seen no official support from Elon Musk's car manufacturer Tesla Inc. (NASDAQ: TSLA) despite it being a widely requested fea

Benzinga

Read news from The Economist, FT, and more,
with one subscription

A Look Into Communication Services Sector Value Stocks

The Meaning Behind Value Stocks

Benzinga

5 Value Stocks To Watch In The Healthcare Sector

What Defines a Value Stock?

Benzinga

5 Value Stocks In The Real Estate Sector

Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.

Benzinga

Insider Weekends: "Adjusted" Insider Buying Increased Last Week With Insiders Purchasing $176.54 Million Of Stock

During a highly volatile week for markets, we saw insiders step up and purchase shares, although in aggregate it looked like both insider buying and selling declined compared to the prior week.

Benzinga

This Is What Whales Are Betting On Qualcomm

Someone with a lot of money to spend has taken a bullish stance on Qualcomm (NASDAQ:QCOM). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Plug Power Whale Trades For May 09

A whale with a lot of money to spend has taken a noticeably bearish stance on Plug Power. Looking at options history for Plug Power (NASDAQ:PLUG) we detected 19 strange trades.

Benzinga

Where BeiGene Stands With Analysts

Within the last quarter, BeiGene (NASDAQ:BGNE) has observed the following analyst ratings:

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

CH-Auto Challenges Li Auto, Nio, Xpeng with U.S. SPAC Listing

Key takeaways:

Benzinga

Achilles Therapeutics Doses First Patient with Higher-dose cNeT in CHIRON Phase 1/2a Trial for Advanced NSCLC

Achilles Therapeutics plc (NASDAQ: ACHL) announced that the first patient has been dosed with personalized clonal neoantigen-reactive T cells, or cNeT, manufactured with the Company's higher-dose VELOS™ Process 2 in the ongoing Phase I/IIa CHIRON clinical trial for the treatment of advanced non-small cell lung can

Benzinga

Why LogicBio Therapeutics Shares Are Popping Off Today

LogicBio Therapeutics Inc (NASDAQ: LOGC) shares are trading higher by 63.48% at $0.81 after the company announced the FDA lifted the clinical hold on its LB-001 Investigational New Drug Application, allowing patient enrollment to resume in the Phase 1/2 SUNRISE trial for pediatric patients with methylmaloni

Benzinga

Preview: comScore's Earnings

comScore (NASDAQ:SCOR) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that comScore will report an earnings per share (EPS) of $-0.14.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Preview: RumbleON's Earnings

RumbleON (NASDAQ:RMBL) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that RumbleON will report an earnings per share (EPS) of $0.99.

Benzinga

Madrigal Announces Debt Funding Of $250M To Back Potential US Resmetirom Launch

Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) secured a $250 million term loan facility from Hercules Capital Inc (NYSE:HTGC), providing additional funding to support the expanded clinical program and ramp-up for a potential US launch of resmetirom. The company drew $50 million from the facility at closing and can draw a further $200 million under the agreement. Related…

Benzinga

New Study To Evaluate Magic Mushroom's Therapeutic Potential On Autistic Adults

Psychedelics continue to garner attention as possible treatments for diverse mental health conditions. Now, Compass Pathways (NASDAQ: CMPS) will undertake a study to evaluate psilocybin’s effects on autistic adults.

Benzinga

A Preview Of Cronos Group's Earnings

Cronos Group (NASDAQ:CRON) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Cronos Group will report an earnings per share (EPS) of $-0.08.

Benzinga

4 Analysts Have This to Say About Tabula Rasa HealthCare

Over the past 3 months, 4 analysts have published their opinion on Tabula Rasa HealthCare (NASDAQ:TRHC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Where Trade Desk Stands With Analysts

Analysts have provided the following ratings for Trade Desk (NASDAQ:TTD) within the last quarter:

Benzinga

Check Out What Whales Are Doing With CRWD

A whale with a lot of money to spend has taken a noticeably bearish stance on CrowdStrike Holdings. Looking at options history for CrowdStrike Holdings (NASDAQ:CRWD) we detected 14 strange trades.

1 … 544 545 546 547

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.